Pfizer quarterly sales surge to record high, driven by Covid vaccine and antiviral treatment Paxlovid
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022. Jennifer Lorenzini | Reuters Pfizer’s second-quarter revenue and profit beat Wall Street expectations, driven by sales of its Covid-19 vaccine and its antiviral treatment Paxlovid. Pfizer booked $27.7 billion in revenue, a 47% increase over the…